As of December 31, 2025, HJ Science Co., Ltd. Class H has 73.60M shares outstanding.
| Shares Outstanding | 73.60M |
As of December 31, 2025, HJ Science Co., Ltd. Class H maintains a current ratio of 4.20, meaning it holds 4.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.76, indicating elevated leverage, while an interest coverage ratio of -1,075.05 demonstrates limited ability to service its debt obligations.
| Current Ratio | 4.20 |
| Quick Ratio | 3.91 |
| Debt / Equity | 3.76 |
| Debt / EBITDA | -0.09 |
| Interest Coverage | -1,075.05 |
Over the twelve months ended December 31, 2025, HJ Science Co., Ltd. Class H posted a negative return on equity (ROE) of -37.92, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -31.31, reflecting losses generated across the asset base. The company generates approximately 125,630.85 in revenue per employee across its workforce of 115.00, a quick read on workforce productivity versus industry peers.
| Return on Equity (ROE) | -37.92 |
| Return on Assets (ROA) | -31.31 |
| Revenue Per Employee | 125,630.85 |
| Employee Count | 115.00 |
Over the twelve months ended December 31, 2025, HJ Science Co., Ltd. Class H recorded 4,451.56 in income tax expense. The company reported a pretax loss of -150.33M and -150.33M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.
| Income Tax | 4,451.56 |
These figures are as of the close on November 17, 2026.
| 50-Day Moving Average | 35.64 |
Over the twelve months ended December 31, 2025, HJ Science Co., Ltd. Class H generated 14.45M in revenue and converted that into -150.33M in net income, yielding earnings per share of -2.04. EBITDA reached -154.34M, while operating income came in at -139.56M.
| Revenue | 14.45M |
| Operating Income | -139.56M |
| Pretax Income | -150.33M |
| Net Income | -150.33M |
| EBITDA | -154.34M |
| EBIT | -157.39M |
| Earnings Per Share (EPS) | -2.04 |
As of December 31, 2025, HJ Science Co., Ltd. Class H holds 418.33M in cash and equivalents against 14.07M in total debt, resulting in a net debt position of 7.00M. Total book value stands at 374.15M, with working capital of 342.21M providing operational flexibility.
| Cash & Cash Equivalents | 418.33M |
| Total Debt | 14.07M |
| Net Debt | 7.00M |
| Equity (Book Value) | 374.15M |
| Book Value Per Share | 5.08 |
| Working Capital | 342.21M |
HJ Science Co., Ltd. Class H produced -99.53M in operating cash flow over the twelve months ended December 31, 2025. After subtracting -1.68M in capital expenditures, free cash flow totaled -101.22M - equivalent to -1.38 per share.
| Operating Cash Flow | -99.53M |
| Capital Expenditures | -1.68M |
| Free Cash Flow | -101.22M |
| FCF Per Share | -1.38 |
These figures cover the twelve months ended December 31, 2025. The operating margin of -965.95 and net profit margin of -1,040.55 provide insight into operational efficiency.
| Operating Margin | -965.95 |
| Pretax Margin | -1,040.52 |
| Profit Margin | -1,040.55 |
| EBITDA Margin | -1,068.26 |
Already premium?